Sunday, October 12, 2008

Pfizer Caught Manipulating Studies Too

I'm really disgusted and disappointed. Pfizer now joins the ranks of Merck, and Schering-Plough (both recently criticized for delaying the release of a study on their best-selling cholesterol medication Vytorin that showed the drug did not slow the growth of plaque in arteries) for purportedly manipulating the publication of scientific studies to bolster the use of its epilepsy drug Neurontin for other disorders, while suppressing research that did not support those uses. For more details, read this NY Times news article, "Experts Conclude Pfizer Manipulated Studies."

I'm particularly irritated given the recent drop in the stock market. Corporations and entities need to be held accountable, especially when the American populace takes it on the chin.

Previous posts:
The Health, Drug, Prescription, and GMP Supersite: Merck - Pharma Gone Bad

Return Home: http://drughealth.blogspot.com/
Return to Mobile Home: http://drughealth.mofuse.mobi/

No comments:

From SkillsPlus International Inc.

Custom Search

Even More Resources, Books, & Things (many from Amazon.com)

FDA, GMPs, QSR, GCP, GLP, GXP:
    GMP Training Gifts & Giveaways